Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Certara (CERT) and Harrow Health (HROW)
Morgan Stanley Lowers Price Target on Certara to $16 From $21, Keeps Equalweight Rating
Certara's Mixed Financial Performance Leads to Hold Rating Amid Market Fluctuations
Certara Analyst Ratings
Certara Stock Rated 'Hold' Amid Mixed Financial Performance and Market Expectations
Bank of America Securities Reaffirms Their Buy Rating on Certara (CERT)
Barclays Maintains Certara(CERT.US) With Hold Rating, Maintains Target Price $16
Certara (CERT) Receives a Hold From Barclays
Certara Analyst Ratings
Certara (CERT) Gets a Hold From Barclays
Market Perform Rating for Certara Amid Strategic Acquisition and Mixed Financial Outlook
Barclays Lowers Price Target on Certara to $16 From $18, Maintains Equalweight Rating
Certara Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL)
Certara Analyst Maintains Hold Rating Amid Mixed Financial Performance and Strategic Developments
Certara (CERT) Gets a Hold From Barclays
Certara (CERT) Gets a Hold From JMP Securities
R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Certara Analyst Ratings
Barclays Remains a Hold on Certara (CERT)